CN

Industrial Layout / INDUSTRIAL LAYOUT

 

gai2.jpg

 

 

A vertically industrial integrated producer specialized in heparin API

The global supplier of chondroitin sulfate (pharmaceutical grade and dietary supplement grade)

  

Over the past 20 years, Dongcheng has been deeply involved in the development of the API business, and already becomes a vertically integrated producer specialized in heparin API, the largest global supplier of chondroitin sulfate at the pharmaceutical grade and dietary supplement grade and one of the largest biochemical API production bases in China.

 

As a leader in the heparin industry, with the rich production experience and strong production capacity, Dongcheng Pharmaceutical continuously strengthens the perfection of heparin industry chain, with a vertically integrated industrial structure to ensure the product quality and traceability.

 

The company has an excellent qualification certification background: the first Chinese supplier of heparin sodium which passes the MFDS GMP audit by the Korea Food & Drug Administration and the PMDA GMP on-site inspection by Japan, and holds the GMP certificates issued by BGV in Hamburg, Germany and CFDA in China, as well as the CEP certificate issued by EDQM in Europe; also, the company participated in the revisions of the Chinese Pharmacopoeia (2010/2015), European Pharmacopoeia and United States Pharmacopeia concerning the heparin sodium API; the company is also the only supplier of heparin sodium which attended the heparin sodium expert panel meeting held at the USP headquarters in the United States.

 

As the largest domestic producer of chondroitin sulfate, Dongcheng currently has the largest production capacity in China and the powerful strength in R&D, quality and sales. In 2016, the company acquired Sino Siam Biotechnique Co., Ltd. to further consolidate its leading position in the global chondroitin industry. In terms of qualification and certification: the company is the first chondroitin producer in China which passes the USP-DSIVP certification of the United States; and holds the CEP certificate issued by EDQM in the European Union, and the GMP certificates issued by BGV in Hamburg, Germany, MFDS in Korea, ANVISA in Brazil and CFDA in China. In view of its technological authority in the domestic biochemical industry, the company was invited to participate in the formulation of the product quality standard for chondroitin sulfate sodium in the Chinese Pharmacopoeia (2010/2015 edition).

 

The company has a well-established global sales network, exports more than 90% of APIs, and sells products to over 40 countries and regions around the world. It has the continuously and stably growing cooperation with the world’s top pharmaceutical companies, and cooperates closely with internationally well-known dietary supplement manufacturers; and also has the good cooperation with prestigious domestic pharmaceutical companies.

 

 

 

Tel:86-0535-6391521\6391522
Email:zxu@dcb-group.com
Add:No.7 ChangBaiShan Road, Yantai Development Zone, ShanDong, China
About Us
Company Profile
Chairman Address
Honors of Dongcheng
Evolutional History
Development Strategy
Corporate Culture
Contact Us
News
Group News
Media Coverage
R&D
Technology Platform
Honors and Qualifications
Advanced Equipment
HR
Talent Concepts
Talent Development
Talent Recruitment
Jobs
IR
Instant Quotes
Regular Reports
Investor Services
Responsibility
Social Welfare
Safety & Environmental Protection
Occupational Health
COPYRIGHT 2020 Yantai Dongcheng Pharmaceutical Group Co., Ltd. All rights reserved 魯ICP備18035060號(hào)-1